Keywords
SARS-CoV-2
Severe acute respiratory syndrome
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To assess the profile of patients hospitalized in a public Covid-19 referral center in Rio de Janeiro. Methods: An observational, cross-sectional, retrospective study was conducted at a public hospital during April 2021. 1413 patients with suspected Covid-19 were included in the study and data were collected from electronic medical records. Results: There was a predominance of older patients (59.12 years of age ± 13.79; mean ± SD) being hospitalized, with no significant male/female difference and the majority of patients came from emergency units. 44.09% of patients occupied intensive care beds. Out of those, 74.52% reported dyspnea, 49.68% had more than 50% pulmonary involvement and the most present chest CT finding was ground-glass opacity. 84.27% had some type of comorbidity and systemic arterial hypertension was the most reported one. The median time elapsed from the onset of symptoms to hospital admission was 8 days (IQR 6-11). Conclusion: Most of those hospitalized with Covid-19 in the analyzed period were elderly, of both sexes. The delay between the onset of symptoms and hospitalization, severe pulmonary involvement and the presence of comorbidities were identified in the records of patients with severe evolution.
References
AHLSTRÖM B, et al. A comparison of impact of comorbidities and demographics on 60-day mortality in ICU patients with Covid-19, sepsis and acute respiratory distress syndrome. Sci Rep., 2022; 12(1): 15703.
CASTRO MC, et al. Characteristics, outcomes and risk factors for mortality of 522 167 patients hospitalised with Covid-19 in Brazil: a retrospective cohort study. BMJ Open. 2021;11(5):e049089.
CHEN X, et al. Dynamic change of Covid-19 lung infection evaluated using co-registration of serial chest CT images. Front Public Health, 2022; 10: 915615.
CIEVS/SES-RJ. 2022. Covid-19 - Casos e óbitos no Estado do Rio de Janeiro divulgados diariamente. Available from: http://sistemas.saude.rj.gov.br. Accessed in: 2022, Sep 20.
DA SILVA CC, et al. Covid-19: Aspectos da origem, fisiopatologia, imunologia e tratamento - uma revisão narrativa. REAS, 2021; 13(3): e6542
GOBALENYA AE, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 2020; 1–9.
HUANG C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395: 497–506.
KLOKNER SGM, et al. Epidemiological profile and risk factors predictors of Covid-19 in southern Brazil. Research, Society and Development, 2021; 10(3): e17710313197.
LIMA SS, et al. Retrospective epidemiology of the SARS-CoV-2 (and Covid-19) epidemic among 27 Brazilian cities. J Clin Virol Plus, 2021; 1(4): 100053.
PERES IT, et al. Sociodemographic factors associated with Covid-19 in-hospital mortality in Brazil. Public Health, 2021; 192: 15-20.
RANZANI OT, et al. Characterisation of the first 250,000 hospital admissions for Covid-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med., 2021; 9(4): 407-418.
RIBEIRO AC, UEHARA SCSA. Systemic arterial hypertension as a risk factor for the severe form of covid-19: scoping review. Revista de Saúde Pública, 2022; 56.
SONG F, et al. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology, 2020; 297(3): E346.
SOUZA FSH, et al. On the analysis of mortality risk factors for hospitalized Covid-19 patients: A data-driven study using the major Brazilian database. PLoS One, 2021; 16(3): e0248580.
SOUZA-SILVA MVR, et al. Hospital characteristics associated with Covid-19 mortality: data from the multicenter cohort Brazilian Registry. Intern Emerg Med., 2022; 25.
WANG D, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020; 323: 1061–1069.
WIERSINGA WJ, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (Covid-19): A Review. JAMA, 2020; 324(8): 782-793.
WORLD HEALTH ORGANIZATION (WHO). WHO Covid-19 Dashboard. Geneva: World Health Organization, 2022. Available from: https://covid19.who.int/. Accessed in: 2022, Sep 26.
YOUNUS S, et al. A novel chest CT severity score in Covid-19 and its correlation with severity and prognosis of the lung disease: A retrospective cohort study. Ann Med Surg., 2022; 82: 104692.
ZHANG JJ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 2020; 75(7): 1730-1741.
ZHENG Z, et al. Risk factors of critical & mortal Covid-19 cases: A systematic literature review and meta-analysis. J Infect., 2020; 81(2): e16-e25.
ZHU N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med., 2020; 382(8): 727-733.